Gross Margin

With soaring revenues and a landmark Microsoft AI deal, A10 Networks is redefining its role. Is this the playbook for winning the AI infrastructure wars?

The clean-living brand's revenue is down, but profits and confidence are soaring. A deep dive into how strategic cuts are building a more durable company.

With a new $345 genome and major clinical wins, PacBio pushes boundaries. But can its strategic restructuring and bold R&D overcome mounting financial losses?

The hormone optimization leader's stock tumbles after Q2 results show a net loss and declining revenue, revealing the prolonged impact of its January recall.

KORU Medical posts record profits, but the real story is its strategic overhaul. We dissect its oncology pivot and digital tech bet for long-term value.

SmartRent’s surge to profitability and massive IoT booking growth signals a new era for rental housing, proving the digital backbone of our cities is here.

XPEL smashes Q2 estimates with record revenue, fueled by explosive China growth. But a costly manufacturing pivot tests its long-term strategy.

CDW's Q2 earnings beat expectations with a 10% sales jump, thanks to AI and cloud demand. But a dip in gross margins and restructuring costs spooked the market.

Pyxus International's Q1 sales fell, but a forensic look reveals a firm mastering a flooded market, boosting margins and shoring up its financial foundations.

NCR Atleos reports a 67% profit jump, driven by its service-led model. This financial strength fast-tracks its integration with Brink's, reshaping financial access.

LeMaitre reports double-digit growth driven by its Artegraft product, but misses analyst estimates. A deep dive into its global strategy and financial health.

Facing revenue headwinds from currency shifts and regulatory hurdles, China's Jin Medical doubles down on R&D and operational efficiency. A look inside their strategy.

Revolve Group boasts a stellar quarter with soaring sales and customer growth, but a one-time tariff refund artificially inflates profits, masking rising costs and negative cash flow.

DDC Enterprise reports a 28% revenue surge, but the real story is how its food business funds an ambitious Bitcoin treasury and shareholder value strategy.

Amid a truck market slump, Core Molding Technologies reveals a strategic shift, leveraging new ventures in energy storage and a major expansion in Mexico.

Shoals Technologies posts a 47% revenue surge and a record $801M backlog, yet shrinking profits reveal the immense operational friction of wiring the energy transition.

Ichor Holdings posts impressive Q2 growth, signaling a wider industry rebound. A $200M capital raise and disciplined strategy position it for the next tech supercycle.

A securities fraud lawsuit hits battery maker Microvast, alleging a pattern of false statements. We dissect the short-seller report, CFO exit, and missed targets.

QHSLab flips to Q2 profit, driven by a recurring revenue model that's reshaping primary care. Is its strategic debt cleanup the key to sustainable growth?

Autolus Therapeutics reports a 100% year-over-year sales jump and a stunning gross margin reversal, securing a $250M credit facility to fund its next big move.